- Home
- BOSC vs SABS Comparison
BOSC vs SABS Comparison
Compare BOSC & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOSC
- SABS
- Stock Information
- Founded
- BOSC 1990
- SABS 2014
- Country
- BOSC Israel
- SABS United States
- Employees
- BOSC N/A
- SABS N/A
- Industry
- BOSC Computer Communications Equipment
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- BOSC Telecommunications
- SABS Health Care
- Exchange
- BOSC Nasdaq
- SABS Nasdaq
- Market Cap
- BOSC 29.6M
- SABS 31.2M
- IPO Year
- BOSC 1996
- SABS N/A
- Fundamental
- Price
- BOSC $5.61
- SABS $2.96
- Analyst Decision
- BOSC
- SABS Strong Buy
- Analyst Count
- BOSC 0
- SABS 3
- Target Price
- BOSC N/A
- SABS $9.00
- AVG Volume (30 Days)
- BOSC 100.6K
- SABS 446.7K
- Earning Date
- BOSC 11-25-2025
- SABS 11-06-2025
- Dividend Yield
- BOSC N/A
- SABS N/A
- EPS Growth
- BOSC 55.92
- SABS N/A
- EPS
- BOSC 0.52
- SABS N/A
- Revenue
- BOSC $46,768,000.00
- SABS $114,698.00
- Revenue This Year
- BOSC N/A
- SABS N/A
- Revenue Next Year
- BOSC N/A
- SABS N/A
- P/E Ratio
- BOSC $10.67
- SABS N/A
- Revenue Growth
- BOSC 15.66
- SABS N/A
- 52 Week Low
- BOSC $2.50
- SABS $1.00
- 52 Week High
- BOSC $5.50
- SABS $6.60
- Technical
- Relative Strength Index (RSI)
- BOSC 75.29
- SABS 65.50
- Support Level
- BOSC $4.88
- SABS $2.82
- Resistance Level
- BOSC $5.05
- SABS $3.19
- Average True Range (ATR)
- BOSC 0.21
- SABS 0.23
- MACD
- BOSC 0.05
- SABS 0.07
- Stochastic Oscillator
- BOSC 100.00
- SABS 84.40
About BOSC B.O.S. Better Online Solutions
BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.